THIS WEEK
May 18, 2000
in the New England Journal of Medicine

 


Treatment of Chronic Depression
graphPatients with chronic forms of major depression are difficult to treat, and the relative effectiveness of medications and psychotherapy is uncertain. This study compared nefazodone, a cognitive behavioral-analysis system of psychotherapy, and the two in combination for the short-term treatment of 681 adults with a chronic nonpsychotic major depressive disorder. Over a 12-week period, they found that although about half the patients had a response to either nefazodone or psychotherapy alone, the combination of the two was significantly more effective than either treatment alone.

Discontinuing Sedation during Mechanical Ventilation
Critically ill patients receiving mechanical ventilation are often given continuous infusions of sedative and analgesic drugs. These infusions may make it difficult to evaluate mental status and to determine when mechanical ventilation can be discontinued. Among 128 patients receiving mechanical ventilation in the intensive care unit, those in whom sedative infusions were interrupted daily had a shorter duration of mechanical ventilation and earlier discharge from the intensive care unit than patients in whom infusions were not interrupted.

Coronary Calcification in Young Adults on Dialysis
Older adults with end-stage renal disease treated by dialysis are at high risk for coronary artery disease, but whether children and young adults with end-stage renal disease are similarly affected is not known. A cardinal anatomical feature of coronary artery disease is coronary-artery calcification, which can be detected noninvasively by electron-beam computed tomography. The authors found that among 39 patients under the age of 30 with end-stage renal disease treated by dialysis, 36 percent had coronary-artery calcification, as compared with 5 percent of 60 normal subjects.

Levodopa or Ropinirole in Early Parkinson's Disease?
Dyskinesia is a troublesome and common side effect of treatment with levodopa. In this double-blind trial, 268 patients with early Parkinson's disease were assigned to treatment with either levodopa or ropinirole, a dopamine agonist. By the end of five years, the rates of dyskinesia were 45 percent with levodopa and 20 percent with ropinirole. The authors conclude that early Parkinsonıs disease can be managed with a reduced risk of dyskinesia by initiating treatment with ropinirole alone and supplementing it with levodopa if necessary.

Clinical Investigators and the Pharmaceutical Industry

Concern is increasing about the relation between clinical investigators and the pharmaceutical industry. Although new drugs and medical devices have led to advances in therapy and diagnosis, some believe industry has too much influence over the work of the research community. There is evidence that researchers with ties to drug companies are more likely to report results favorable to those companiesı products than researchers without such ties. A Health Policy Report discusses some of the problems raised by industry funding of drug trials. It concludes that an essential ingredient of any solution is increased independence for investigators to conduct and publish their research. In a related editorial, Angell discusses the extent to which academic medicine has become intertwined with the pharmaceutical and biotechnology industries and the benefits and risks of this state of affairs.